We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

UAS Labs Warning Letter

This article was originally published in The Tan Sheet

06 Jun 2005

News

Executive Summary

Eden Prairie, Minn.-based firm must revise product labeling claims for its DDS-Plus non-dairy powder and capsules, according to a Warning Letter received by the firm following an FDA inspection of its facility in January. The district office singled out Internet claims for the probiotic supplements, including the statement "Bifidus bacteria may play a role in fighting colon cancer and reducing blood cholesterol." Statements touting Joint Formula Glucosamine/Chondroitin with Boswellia 8s MSM as a "natural approach to arthritis pain" also are cited. FDA says the statements render the products unapproved new drugs under the FD&C Act...